Kymera Therapeutics
Price & Volume
Stats
See more52W Range | $19.44-$68.80 |
Market Cap | $4.8B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $43.7M |
Revenue Growth (YoY) | -26.1% |
Gross Profit (12 Mos) | -$260.8M |
Diluted EPS | -$3.60 |
News
See moreYahoo Finance • 3 days ago
Here Are Wednesday’s Top Wall Street Analyst Research Calls: DHL Group, NetApp, Nutanix, Oracle, Snowflake, Urban Outfitters, Zscaler and More
Yahoo Finance • 4 days ago
Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
Yahoo Finance • 5 days ago
Kymera Therapeutics to Participate in Upcoming December Investor Conferences
Yahoo Finance • 26 days ago
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
About
CEO | Dr. Nello Mainolfi M.D., Ph.D. |
Address | 500 North Beacon Street, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 225 |
